Fig. 2From: Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapyOverall changes of hormone levels during therapy regarding therapy outcome showing a significant rise in circulating FSH levels in patients with complete or partial response and a significant decrease of the LH/FSH ratio in the responder subset, *p < 0.05. SD/PD (n = 17), CR/PR (n = 11)Back to article page